FDA.reportPublic FDA data

bacitracin 0.4 UNT/MG / lidocaine 0.04 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment

RxCUI
1098397
RxNorm name
bacitracin 0.4 UNT/MG / lidocaine 0.04 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment
Display name
Bacitracin/Lidocaine/Neomycin/Polymyxin B (Topical)
Full name
bacitracin 0.4 UNT/MG / lidocaine 0.04 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment
Term type
SCD
Status
Active
Strength
0.4-0.04-0.0035-5 var units
Dose form
Ointment
Route
Topical
Updated
2026-06-15 07:02:05

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
052011
Active start
052011
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
bacitracin zinc0.4 UNT / 1 MGbacitracinbacitracin
lidocaine hydrochloride0.04 MG / 1 MGlidocainelidocaine
neomycin sulfate0.0035 MG / 1 MGneomycinneomycin
polymyxin B sulfate5 UNT / 1 MGpolymyxin Bpolymyxin B

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Ointment316985

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
bacitracin1291
lidocaine6387
neomycin7299
polymyxin B8536

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRbacitracin 0.4 UNT/MG / lidocaine 0.04 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical OintmentNAMES
RxNorm Namebacitracin 0.4 UNT/MG / lidocaine 0.04 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical OintmentNAMES
RxNorm Synonymbacitracin 400 UNT / lidocaine 40 MG / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical OintmentNAMES
TTYSCDATTRIBUTES
SPL_SET_IDb5725d7a-2a46-415a-9b90-33dd52439217CODES
RxCUI1098397CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
50332003100rxnav_ndcsyes
50332003102rxnav_ndcsyes
47682093573rxnav_historical
68421650000rxnav_historical
69103240001rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
fc0dc0be-1d9b-4ff0-ab48-b0fdd7b1cfcebacitracin 400 UNT / lidocaine 40 MG / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical OintmentPSN2SUPER BIOTIC WOUND OINTMENT20100915
fc0dc0be-1d9b-4ff0-ab48-b0fdd7b1cfcebacitracin 0.4 UNT/MG / lidocaine 0.04 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical OintmentSCD2SUPER BIOTIC WOUND OINTMENT20100915
fc0dc0be-1d9b-4ff0-ab48-b0fdd7b1cfcebacitracin 400 UNT / lidocaine 40 MG / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical OintmentSY2SUPER BIOTIC WOUND OINTMENT20100915
0d3af5c2-e24a-4070-a059-5f7ceacb6540bacitracin 0.4 UNT/MG / lidocaine 0.04 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical OintmentSCD120140724
0d3af5c2-e24a-4070-a059-5f7ceacb6540bacitracin 400 UNT / lidocaine 40 MG / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical OintmentPSN120140724
0d3af5c2-e24a-4070-a059-5f7ceacb6540bacitracin 400 UNT / lidocaine 40 MG / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical OintmentSY120140724
b5725d7a-2a46-415a-9b90-33dd52439217bacitracin 400 UNT / lidocaine 40 MG / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical OintmentSY1TRIBIOTIC-LC20121018
b5725d7a-2a46-415a-9b90-33dd52439217bacitracin 0.4 UNT/MG / lidocaine 0.04 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical OintmentSCD1TRIBIOTIC-LC20121018
b5725d7a-2a46-415a-9b90-33dd52439217bacitracin 400 UNT / lidocaine 40 MG / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical OintmentPSN1TRIBIOTIC-LC20121018

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
0d3af5c2-e24a-4070-a059-5f7ceacb6540Provision Medical | Safetec of America, Inc.20140724
b5725d7a-2a46-415a-9b90-33dd52439217TRIBIOTIC-LCHART Health20121018
fc0dc0be-1d9b-4ff0-ab48-b0fdd7b1cfceSUPER BIOTIC WOUND OINTMENTCintas First Aid & Safety | Safetec of America, Inc.20100915

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCA07AAAntibioticsATC1-4polymyxin B
ATCS01AAAntibioticsATC1-4neomycin
ATCR02ABAntibioticsATC1-4neomycin
ATCA07AAAntibioticsATC1-4neomycin
ATCS01AAAntibioticsATC1-4bacitracin
ATCR02ABAntibioticsATC1-4bacitracin
ATCS01AAAntibioticsATC1-4polymyxin B
ATCS02AAAntiinfectivesATC1-4polymyxin B
ATCS03AAAntiinfectivesATC1-4polymyxin B
ATCB05CAAntiinfectivesATC1-4neomycin
ATCS03AAAntiinfectivesATC1-4neomycin
ATCS02AAAntiinfectivesATC1-4neomycin
ATCA01ABAntiinfectives and antiseptics for local oral treatmentATC1-4neomycin
ATCS01HALocal anestheticsATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
ATCJ01GBOther aminoglycosidesATC1-4neomycin
ATCJ01XXOther antibacterialsATC1-4bacitracin
ATCD06AXOther antibiotics for topical useATC1-4neomycin
ATCD06AXOther antibiotics for topical useATC1-4bacitracin
ATCJ01XBPolymyxinsATC1-4polymyxin B
FDASPLD000617AminoglycosidesCHEMhas_chemical_structureneomycin
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175477Aminoglycoside AntibacterialEPChas_epcneomycin
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000175499Polymyxin-class AntibacterialEPChas_epcpolymyxin B
FDASPLN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pebacitracin
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD001414BacitracinCHEMhas_ingredientbacitracin
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD009355NeomycinCHEMhas_ingredientneomycin
MEDRTD011112Polymyxin BCHEMhas_ingredientpolymyxin B
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD016470BacteremiaDISEASEmay_treatpolymyxin B
MEDRTD001424Bacterial InfectionsDISEASEmay_preventneomycin
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withneomycin
MEDRTD004342Drug HypersensitivityDISEASEci_withpolymyxin B
MEDRTD004342Drug HypersensitivityDISEASEci_withbacitracin
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD004653EmpyemaDISEASEmay_treatbacitracin
MEDRTD004761Enterocolitis, PseudomembranousDISEASEmay_treatbacitracin
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatpolymyxin B
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatneomycin
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD015818Eye Infections, BacterialDISEASEmay_treatbacitracin
MEDRTD015818Eye Infections, BacterialDISEASEmay_treatpolymyxin B
MEDRTD005767Gastrointestinal DiseasesDISEASEmay_treatpolymyxin B
MEDRTD006192Haemophilus InfectionsDISEASEmay_treatpolymyxin B
MEDRTD006501Hepatic EncephalopathyDISEASEmay_treatneomycin
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD015212Inflammatory Bowel DiseasesDISEASEci_withneomycin
MEDRTD007415Intestinal ObstructionDISEASEci_withneomycin
MEDRTD007674Kidney DiseasesDISEASEci_withbacitracin
MEDRTD007710Klebsiella InfectionsDISEASEmay_treatpolymyxin B
MEDRTD016920Meningitis, BacterialDISEASEmay_treatpolymyxin B
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD010032Otitis ExternaDISEASEmay_treatpolymyxin B
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD011014PneumoniaDISEASEmay_treatbacitracin
MEDRTD011552Pseudomonas InfectionsDISEASEmay_treatpolymyxin B
MEDRTD012871Skin DiseasesDISEASEmay_treatpolymyxin B
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatneomycin
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatbacitracin
MEDRTD017192Skin Diseases, BacterialDISEASEmay_preventbacitracin
MEDRTD018461Soft Tissue InfectionsDISEASEmay_treatpolymyxin B
MEDRTD013203Staphylococcal InfectionsDISEASEmay_treatbacitracin
MEDRTD013290Streptococcal InfectionsDISEASEmay_treatbacitracin
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD001745Urinary Bladder DiseasesDISEASEmay_treatpolymyxin B
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTD014947Wounds and InjuriesDISEASEmay_treatpolymyxin B
MEDRTN0000000226Acid-Base ActivityMOAhas_moapolymyxin B
MEDRTN0000009954Cell Membrane Fusion Complex InteractionsMOAhas_moabacitracin
MEDRTN0000000227Cholinergic Nicotinic AntagonistsMOAci_moapolymyxin B
MEDRTN0000000163Enzyme InteractionsMOAhas_moabacitracin
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moaneomycin
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008346Cellular Structure AlterationPEhas_pepolymyxin B
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pebacitracin
MEDRTN0000008841Decreased Protein SynthesisPEhas_peneomycin
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008953Decreased Striated Muscle ContractionPEci_pepolymyxin B
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.4 UNT/MG / 0.04 MG/MG / 0.0035 MG/MG / 5 UNT/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSCD
CODESRxCUI1098397
CODESSPL_SET_IDb5725d7a-2a46-415a-9b90-33dd52439217
NAMESPrescribable Synonymbacitracin 400 UNT / lidocaine 40 MG / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment
NAMESRXNAV_STRbacitracin 0.4 UNT/MG / lidocaine 0.04 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment
NAMESRxNorm Namebacitracin 0.4 UNT/MG / lidocaine 0.04 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment
NAMESRxNorm Synonymbacitracin 400 UNT / lidocaine 40 MG / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment
SOURCESSourceMetathesaurus FDA Structured Product Labels